Nondestructive analysis of crystals within rat liver and duodenum samples by spectroscopic means.
Walker
Dwight S
DS
GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina 27709, USA.
D000818:Animals; D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000633:toxicity; D044482:Benzeneacetamides / Q000493:pharmacokinetics; D003460:Crystallization; D004386:Duodenum / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D011355:Prodrugs / Q000493:pharmacokinetics / Q000633:toxicity; D051381:Rats; D018894:Reverse Transcriptase Inhibitors / Q000493:pharmacokinetics / Q000633:toxicity; D017550:Spectroscopy, Fourier Transform Infrared / Q000295:instrumentation / Q000379:methods*; D013059:Spectrum Analysis, Raman / Q000295:instrumentation / Q000379:methods*
C494195:2-(4-chloro-2-(3-chloro-5-cyanobenzoyl)phenoxy)-N-(2-methyl-4 ((propionylamino)sulfonyl)phenyl)acetamide; D019380:Anti-HIV Agents; D044482:Benzeneacetamides; D011355:Prodrugs; D018894:Reverse Transcriptase Inhibitors